Global biotherapeutics leader CSL Behring, located in King of Prussia, announced that it will proceed with a global Phase 3 cardiovascular morbidity and mortality trial…
Forgot your password?
Lost your password? Please enter your email address. You will receive mail with link to set new password.
Back to login
